SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-032781
Filing Date
2024-02-13
Accepted
2024-02-13 06:06:55
Documents
2
Group Members
BIOTECH GROWTH N.V.BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d771197dsc13ga.htm SC 13G/A 61828
2 EX-99.A d771197dex99a.htm EX-99.A 12419
  Complete submission text file 0001193125-24-032781.txt   75901
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91387 | Film No.: 24622458
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)